Neurogene Inc. Alternatives & Competitors
12 companies similar to Neurogene Inc. — Reimagining the future for rare neurological diseases
Companies similar to Neurogene Inc.
Autifony Therapeutics
Autifony are dedicated to developing new medicines to treat rare genetic CNS disorders
Locanabio, Inc.
Creating RNA-targeting gene therapies to treat devastating diseases
San Diego, United States
Prevail Therapeutics
Wholly owned subsidiary of Eli Lilly and Company
New York, United States
Forge Biologics
A member of Ajinomoto Bio-Pharma Services
Columbus, United States
Track all Neurogene Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Ascidian Therapeutics
Rewriting RNA
Boston, United States
Tevard Biosciences
Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic d...
Cambridge, United States
HuidaGene Therapeutics
辉大，给患者回答 | Answering the Patients！
Shanghai, China
Avalo Therapeutics
Innovation driven by compassion.
Rockville, United States
Excision BioTherapeutics
Developing CRISPR-based therapies intended to cure viral infectious diseases.
Watertown, United States
Homology Medicines
Dedicated to addressing the root cause of rare genetic diseases and promising hope for pat...
Sania Therapeutics
Precision genetic neuromodulation for neural circuit dysfunction
London, United Kingdom
Axovia Therapeutics
Driving gene therapy breakthroughs to develop transformative AAV treatments for patients w...
London, United Kingdom
About Neurogene Inc.
Neurogene Inc., founded in 2018, is making significant strides in the Biotechnology sector by developing genetic medicines aimed at treating rare neurological diseases. With the slogan "Reimagining the future for rare neurological diseases," the company is on a mission to address unmet medical needs in the field of neu...
Gene therapy development, Proprietary transgene regulation technology, Clinical research and trials, Patient and family support, Manufacturing of genetic medicines
Patients with rare neurological diseases, Families of patients, Healthcare professionals, Biotechnology and pharmaceutical partners, Investors
Rare Neurological Diseases, Genetic Medicines, Genomics Revolution, Neurological Disorders, Therapeutics Development, Gene Therapy, Pediatric Neurology, Developmental Delay, Medical Innovation, Global Collaboration, Rare Disease Solutions, Precision Medicine, Patient-Centric Approach
B2B2C, B2B
Product Sales, Licensing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Neurogene Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Neurogene Inc. on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 30 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
